IDEXX Laboratories, Inc. operates in the healthcare sector with a focus on diagnostics and testing services for animals and water quality. With a solid market position and diversified portfolio, IDEXX holds promising growth potential. The company’s operational emphasis across multiple specialized segments enhances its long-term financial outlook.
The fundamental analysis of IDEXX Laboratories shows a stable outlook, with some areas to watch for improvement.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 1 |
The historical fundamentals reveal consistency over time, highlighting stable financial management.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-10-30 | 3 | 3 | 5 | 5 | 1 | 1 | 1 |
| Previous | 0 | 3 | 5 | 5 | 1 | 1 | 1 |
Analysts suggest a bullish trend for IDEXX with strong potential for price growth.
| High | Low | Median | Consensus |
|---|---|---|---|
| $785 | $640 | $721 | $716.75 |
The analyst sentiment showcases a predominantly positive outlook with a strong inclination towards buying.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 11 | |
| Hold | 8 | |
| Sell | 1 | |
| Strong Sell | 0 |
IDEXX Laboratories, Inc. holds a solid position in the diagnostics market, underpinned by robust returns and innovative product offerings. Analyst targets suggest further stock growth potential, though a closer watch on debt-to-equity ratios is advisable. The lack of strong sell recommendations reflects positive market sentiment, signaling investor confidence. Yet, the price multiples suggest a need for cautious valuation. Overall, with growth prospects in place, IDEXX remains a promising investment avenue in a dynamic healthcare market.